Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Metagenomi Inc (MGX)

Metagenomi Inc (MGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 126,867
  • Shares Outstanding, K 37,424
  • Annual Sales, $ 44,760 K
  • Annual Income, $ -68,260 K
  • EBIT $ -88 M
  • EBITDA $ -93 M
  • 60-Month Beta N/A
  • Price/Sales 2.60
  • Price/Cash Flow N/A
  • Price/Book 0.45

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.62
  • Number of Estimates 4
  • High Estimate -0.45
  • Low Estimate -0.88
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.61 +112.11%
on 11/20/24
4.92 -30.59%
on 12/10/24
+1.66 (+95.14%)
since 11/18/24
3-Month
1.61 +112.11%
on 11/20/24
4.92 -30.59%
on 12/10/24
+0.75 (+28.38%)
since 09/18/24

Most Recent Stories

More News
2 ‘Monster’ Stocks to Snap Up Before 2025

Analysts at Jefferies have identified Metagenomi and Structure Therapeutics as two "monster" stocks in the biotech sector, with potential gains of up to 1,000%.

GPCR : 27.08 (-13.98%)
MGX : 3.39 (-0.08%)
Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”

MGX : 3.39 (-0.08%)
Metagenomi Reports Sustained Factor VIII Activity in Nonhuman Primate Study for Hemophilia A Treatment Candidate MGX-001

Metagenomi reports sustained Factor VIII activity in NHPs, supporting MGX-001's potential as a hemophilia A treatment.Quiver AI SummaryMetagenomi, Inc. has reported promising results from its ongoing preclinical...

MGX : 3.39 (-0.08%)
Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting

MGX : 3.39 (-0.08%)
Metagenomi: Q3 Earnings Snapshot

Metagenomi: Q3 Earnings Snapshot

MGX : 3.39 (-0.08%)
Metagenomi Reports Business Updates and Third Quarter 2024 Financial Results

MGX : 3.39 (-0.08%)
Metagenomi To Present New Preclinical Hemophilia A Data at American Society of Hematology (ASH) 66th Annual Meeting

MGX : 3.39 (-0.08%)
Metagenomi Presents Novel, Highly Specific and Efficient Adenine Base Editors for Broad Genome Editing at ESGCT

MGX : 3.39 (-0.08%)
Metagenomi Presents Compact SMART Editing Platform at AIChE 7th International Conference on CRISPR Technologies

MGX : 3.39 (-0.08%)
Metagenomi: Q2 Earnings Snapshot

Metagenomi: Q2 Earnings Snapshot

MGX : 3.39 (-0.08%)

Business Summary

Metagenomi Inc. is a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived gene editing toolbox. Metagenomi Inc. is based in EMERYVILLE, Calif.

See More

Key Turning Points

3rd Resistance Point 4.18
2nd Resistance Point 3.90
1st Resistance Point 3.65
Last Price 3.39
1st Support Level 3.12
2nd Support Level 2.84
3rd Support Level 2.59

See More

52-Week High 12.74
Fibonacci 61.8% 8.49
Fibonacci 50% 7.17
Fibonacci 38.2% 5.86
Last Price 3.39
52-Week Low 1.61

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar